Cargando…

Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse

Gluten proteins are known as immunological triggers for inflammation resulting in mucosal lesions in patients with coeliac disease (CD). Adherence to a strict gluten-free diet (GFD) is currently known as the only effective treatment for CD. In this study, we performed a systematic review and dose-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Rostami-Nejad, Mohammad, Asri, Nastaran, Olfatifar, Meysam, Khorsand, Babak, Houri, Hamidreza, Rostami, Kamran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057462/
https://www.ncbi.nlm.nih.gov/pubmed/36986121
http://dx.doi.org/10.3390/nu15061390
_version_ 1785016373360984064
author Rostami-Nejad, Mohammad
Asri, Nastaran
Olfatifar, Meysam
Khorsand, Babak
Houri, Hamidreza
Rostami, Kamran
author_facet Rostami-Nejad, Mohammad
Asri, Nastaran
Olfatifar, Meysam
Khorsand, Babak
Houri, Hamidreza
Rostami, Kamran
author_sort Rostami-Nejad, Mohammad
collection PubMed
description Gluten proteins are known as immunological triggers for inflammation resulting in mucosal lesions in patients with coeliac disease (CD). Adherence to a strict gluten-free diet (GFD) is currently known as the only effective treatment for CD. In this study, we performed a systematic review and dose-response meta-analysis on data from previous studies to investigate the association between different gluten doses administered and the risk of CD relapse. Electronic databases were systematically searched to retrieve studies that investigated the response of CD patients to different amounts of gluten intake and evaluated the clinical, serologic, and/or histologic evidence to recognize disease relapse. Study-specific relative risks (RRs) were combined using a random effects model. A total of 440 identified published papers were screened, of which 7 records were selected following full-text reviewing and eligibility assessment for dose-response meta-analysis. According to our analysis, the risk of CD relapse is estimated to be 0.2% (RR: 1.002; 95% CI: 1.001 to 1.004) following the consumption of 6 mg gluten/day, which was increased to 7% (RR: 1.07; 95% CI: 1.03 to 1.10), 50% (RR: 1.50; 95% CI: 1.23 to 1.82), 80% (RR: 1.80; 95% CI: 1.36 to 2.38), and 100% (RR: 2.00; 95% CI: 1.43 to 2.78) by the daily intake of 150, 881, 1276, and 1505 mg gluten, respectively. Although good adherence to a GFD can adequately control CD-related symptoms, disease relapse might happen even with a very low dose of gluten, and the duration of exposure to gluten is also an important matter. The current literature has substantial limitations, such as relying on the data from just a few countries that were different in terms of the amount of gluten administered, the duration of the challenge, etc. Therefore, more randomized clinical trials using a standardized gluten challenge protocol are needed to confirm the findings of the present study.
format Online
Article
Text
id pubmed-10057462
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100574622023-03-30 Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse Rostami-Nejad, Mohammad Asri, Nastaran Olfatifar, Meysam Khorsand, Babak Houri, Hamidreza Rostami, Kamran Nutrients Systematic Review Gluten proteins are known as immunological triggers for inflammation resulting in mucosal lesions in patients with coeliac disease (CD). Adherence to a strict gluten-free diet (GFD) is currently known as the only effective treatment for CD. In this study, we performed a systematic review and dose-response meta-analysis on data from previous studies to investigate the association between different gluten doses administered and the risk of CD relapse. Electronic databases were systematically searched to retrieve studies that investigated the response of CD patients to different amounts of gluten intake and evaluated the clinical, serologic, and/or histologic evidence to recognize disease relapse. Study-specific relative risks (RRs) were combined using a random effects model. A total of 440 identified published papers were screened, of which 7 records were selected following full-text reviewing and eligibility assessment for dose-response meta-analysis. According to our analysis, the risk of CD relapse is estimated to be 0.2% (RR: 1.002; 95% CI: 1.001 to 1.004) following the consumption of 6 mg gluten/day, which was increased to 7% (RR: 1.07; 95% CI: 1.03 to 1.10), 50% (RR: 1.50; 95% CI: 1.23 to 1.82), 80% (RR: 1.80; 95% CI: 1.36 to 2.38), and 100% (RR: 2.00; 95% CI: 1.43 to 2.78) by the daily intake of 150, 881, 1276, and 1505 mg gluten, respectively. Although good adherence to a GFD can adequately control CD-related symptoms, disease relapse might happen even with a very low dose of gluten, and the duration of exposure to gluten is also an important matter. The current literature has substantial limitations, such as relying on the data from just a few countries that were different in terms of the amount of gluten administered, the duration of the challenge, etc. Therefore, more randomized clinical trials using a standardized gluten challenge protocol are needed to confirm the findings of the present study. MDPI 2023-03-14 /pmc/articles/PMC10057462/ /pubmed/36986121 http://dx.doi.org/10.3390/nu15061390 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Rostami-Nejad, Mohammad
Asri, Nastaran
Olfatifar, Meysam
Khorsand, Babak
Houri, Hamidreza
Rostami, Kamran
Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse
title Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse
title_full Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse
title_fullStr Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse
title_full_unstemmed Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse
title_short Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse
title_sort systematic review and dose-response meta-analysis on the relationship between different gluten doses and risk of coeliac disease relapse
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057462/
https://www.ncbi.nlm.nih.gov/pubmed/36986121
http://dx.doi.org/10.3390/nu15061390
work_keys_str_mv AT rostaminejadmohammad systematicreviewanddoseresponsemetaanalysisontherelationshipbetweendifferentglutendosesandriskofcoeliacdiseaserelapse
AT asrinastaran systematicreviewanddoseresponsemetaanalysisontherelationshipbetweendifferentglutendosesandriskofcoeliacdiseaserelapse
AT olfatifarmeysam systematicreviewanddoseresponsemetaanalysisontherelationshipbetweendifferentglutendosesandriskofcoeliacdiseaserelapse
AT khorsandbabak systematicreviewanddoseresponsemetaanalysisontherelationshipbetweendifferentglutendosesandriskofcoeliacdiseaserelapse
AT hourihamidreza systematicreviewanddoseresponsemetaanalysisontherelationshipbetweendifferentglutendosesandriskofcoeliacdiseaserelapse
AT rostamikamran systematicreviewanddoseresponsemetaanalysisontherelationshipbetweendifferentglutendosesandriskofcoeliacdiseaserelapse